{
  "title": "Progression-Free Survival Under Immune Checkpoint Inhibitors for Metastatic Non-Small-Cell Lung Cancer: A Retrospective Cohort Study.",
  "pmid": "40759835",
  "doi": null,
  "affiliations": [
    "Institut de Cancérologie de l'Ouest, 44805, Saint-Herblain, France.",
    "Department of Medical Oncology, University Hospital of Brest, Brest, France.",
    "Institut de Cancérologie de l'Ouest, 44805, Saint-Herblain, France.",
    "Nantes Université, Univ Angers, INSERM, CNRS, CRCI2NA, F-44000, Nantes, France.",
    "Institut de Cancérologie de l'Ouest, 44805, Saint-Herblain, France.",
    "Institut de Cancérologie de l'Ouest, 44805, Saint-Herblain, France.",
    "Institut de Cancérologie de l'Ouest, 44805, Saint-Herblain, France.",
    "Institut de Cancérologie de l'Ouest, F-49055, Angers, France.",
    "Institut de Cancérologie de l'Ouest, 44805, Saint-Herblain, France.",
    "Medical Oncology Department, Hospital Clinic de Barcelona, Barcelona, Spain.",
    "Laboratory of Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain.",
    "Department of Medicine, University of Barcelona, Barcelona, Spain.",
    "Medical Oncology Department, Hospital Clinic de Barcelona, Barcelona, Spain.",
    "Laboratory of Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain.",
    "Department of Medicine, University of Barcelona, Barcelona, Spain.",
    "Institut de Cancérologie de l'Ouest, 44805, Saint-Herblain, France. Judith.raimbourg@ico.unicancer.fr.",
    "Nantes Université, Univ Angers, INSERM, CNRS, CRCI2NA, F-44000, Nantes, France. Judith.raimbourg@ico.unicancer.fr."
  ]
}